These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2324496)

  • 41. Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release.
    Gee AP; Boyle MD; Borsos T
    J Immunol; 1980 Apr; 124(4):1905-10. PubMed ID: 7365242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
    Zalman LS; Wood LM; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL; Monahan JB; Brickner A; Sodetz JM
    Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
    Ninomiya H; Sims PJ
    J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
    Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE
    Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restriction of cell lysis by homologous complement: I. An analysis of membrane attack complex formation on target membranes.
    Houle JJ; Hoffmann EM; Esser AF
    Blood; 1988 Feb; 71(2):280-6. PubMed ID: 3337896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies of the association of the eighth and ninth components of human complement within the membrane-bound cytolytic complex.
    Monahan JB; Stewart JL; Sodetz JM
    J Biol Chem; 1983 Apr; 258(8):5056-62. PubMed ID: 6833292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chimeric horse/human recombinant C9 proteins identify the amino acid sequence in horse C9 responsible for restriction of hemolysis.
    Tomlinson S; Wang Y; Ueda E; Esser AF
    J Immunol; 1995 Jul; 155(1):436-44. PubMed ID: 7541424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane vesiculation protects erythrocytes from destruction by complement.
    Iida K; Whitlow MB; Nussenzweig V
    J Immunol; 1991 Oct; 147(8):2638-42. PubMed ID: 1918984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
    Sims PJ
    Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction between the C8 alpha-gamma and C8 beta subunits of human complement C8: role of the C8 beta N-terminal thrombospondin type 1 module and membrane attack complex/perforin domain.
    Musingarimi P; Plumb ME; Sodetz JM
    Biochemistry; 2002 Sep; 41(37):11255-60. PubMed ID: 12220191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homologous species restriction of the complement-mediated killing of nucleated cells.
    Yamamoto H; Blaas P; Nicholson-Weller A; Hänsch GM
    Immunology; 1990 Aug; 70(4):422-6. PubMed ID: 1697561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
    Sawant-Mane S; Piddlesden SJ; Morgan BP; Holers VM; Koski CL
    J Neuroimmunol; 1996 Sep; 69(1-2):63-71. PubMed ID: 8823377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement.
    Lovelace LL; Cooper CL; Sodetz JM; Lebioda L
    J Biol Chem; 2011 May; 286(20):17585-92. PubMed ID: 21454577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis for membrane attack complex inhibition by CD59.
    Couves EC; Gardner S; Voisin TB; Bickel JK; Stansfeld PJ; Tate EW; Bubeck D
    Nat Commun; 2023 Feb; 14(1):890. PubMed ID: 36797260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. S-protein/vitronectin interaction with the C5b and the C8 of the complement membrane attack complex.
    Su HR
    Int Arch Allergy Immunol; 1996 Aug; 110(4):314-7. PubMed ID: 8768797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
    Young JD; Jiang S; Liu CC; Hasselkus-Light CS
    J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional domains of the alpha subunit of the eighth component of human complement: identification and characterization of a distinct binding site for the gamma chain.
    Brickner A; Sodetz JM
    Biochemistry; 1985 Aug; 24(17):4603-7. PubMed ID: 4063342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.